Cargando…
Disrupted neuronal trafficking in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive, adult-onset neurodegenerative disease caused by degeneration of motor neurons in the brain and spinal cord leading to muscle weakness. Median survival after symptom onset in patients is 3–5 years and no effective therapies are available to treat...
Autores principales: | Burk, Katja, Pasterkamp, R. Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531423/ https://www.ncbi.nlm.nih.gov/pubmed/30721407 http://dx.doi.org/10.1007/s00401-019-01964-7 |
Ejemplares similares
-
Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013) -
Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis
por: Boentert, Matthias
Publicado: (2020) -
Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis
por: Nijssen, Jik, et al.
Publicado: (2017) -
Motor neuron replacement therapy for amyotrophic lateral sclerosis
por: Liu, Bochao, et al.
Publicado: (2022) -
TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)